Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Chronic levodopa administration followed by a washout period increased number and induced phenotypic changes in striatal dopaminergic cells in MPTP-monkeys.

DiCaudo C, Riverol M, Mundiñano IC, Ordoñez C, Hernández M, Marcilla I, Luquin MR.

PLoS One. 2012;7(11):e50842. doi: 10.1371/journal.pone.0050842. Epub 2012 Nov 30.

2.

Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.

San Sebastián W, Guillén J, Manrique M, Belzunegui S, Ciordia E, Izal-Azcárate A, Garrido-Gil P, Vázquez-Claverie M, Luquin MR.

Brain. 2007 May;130(Pt 5):1306-16. Epub 2007 Apr 17.

PMID:
17439984
3.

Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.

Riverol M, Ordóñez C, Collantes M, DiCaudo C, Peñuelas I, Arbizu J, Marcilla I, Luquin MR.

Neurobiol Dis. 2014 Feb;62:250-9. doi: 10.1016/j.nbd.2013.09.014. Epub 2013 Sep 27.

PMID:
24076099
4.

L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.

Huot P, Lévesque M, Morissette M, Calon F, Dridi M, Di Paolo T, Parent A.

J Chem Neuroanat. 2008 Jan;35(1):77-84. Epub 2007 Jul 17.

PMID:
17706922
5.

Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.

Naskar A, Prabhakar V, Singh R, Dutta D, Mohanakumar KP.

J Pineal Res. 2015 Apr;58(3):262-74. doi: 10.1111/jpi.12212. Epub 2015 Feb 23.

PMID:
25626558
6.
7.

l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Holmer HK, Keyghobadi M, Moore C, Meshul CK.

Neuroscience. 2005;136(1):333-41. Epub 2005 Sep 28.

PMID:
16198485
8.

New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis.

Tandé D, Höglinger G, Debeir T, Freundlieb N, Hirsch EC, François C.

Brain. 2006 May;129(Pt 5):1194-200. Epub 2006 Feb 15.

PMID:
16481374
9.

Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.

Neurobiol Dis. 2012 Mar;45(3):1051-67. doi: 10.1016/j.nbd.2011.12.024. Epub 2011 Dec 14.

PMID:
22198503
10.

A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets.

Iravani MM, Syed E, Jackson MJ, Johnston LC, Smith LA, Jenner P.

Eur J Neurosci. 2005 Feb;21(4):841-54.

PMID:
15787691
11.
12.

Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.

Darmopil S, Muñetón-Gómez VC, de Ceballos ML, Bernson M, Moratalla R.

Eur J Neurosci. 2008 Feb;27(3):580-92. doi: 10.1111/j.1460-9568.2008.06040.x.

PMID:
18279311
14.

L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.

Espadas I, Darmopil S, Vergaño-Vera E, Ortiz O, Oliva I, Vicario-Abejón C, Martín ED, Moratalla R.

Neurobiol Dis. 2012 Dec;48(3):271-81. doi: 10.1016/j.nbd.2012.07.012. Epub 2012 Jul 20.

PMID:
22820144
15.

Distinct effects of intranigral L-DOPA infusion in the MPTP rat model of Parkinson's disease.

Reksidler AB, Lima MM, Dombrowski PA, Barnabé GF, Andersen ML, Tufik S, Vital MA.

J Neural Transm Suppl. 2009;(73):259-68.

PMID:
20411784
16.
17.

Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.

Chadi G, Møller A, Rosén L, Janson AM, Agnati LA, Goldstein M, Ogren SO, Pettersson RF, Fuxe K.

Exp Brain Res. 1993;97(1):145-58.

PMID:
7907549
18.

Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.

Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T.

Neuropharmacology. 2010 Jan;58(1):286-96. doi: 10.1016/j.neuropharm.2009.06.030. Epub 2009 Jul 2.

PMID:
19576910
19.

Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration.

Palfi S, Leventhal L, Chu Y, Ma SY, Emborg M, Bakay R, Déglon N, Hantraye P, Aebischer P, Kordower JH.

J Neurosci. 2002 Jun 15;22(12):4942-54.

20.

Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.

Albanese A, Granata R, Gregori B, Piccardi MP, Colosimo C, Tonali P.

Neuroscience. 1993 Aug;55(3):823-32.

PMID:
8105418

Supplemental Content

Support Center